Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01208051
Recruitment Status : Active, not recruiting
First Posted : September 23, 2010
Last Update Posted : December 2, 2019
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 1, 2020
Study Completion Date : No date given